P. Männistö

发表

Molecular dynamics simulations of the enzyme Catechol-O-Methyltransferase: methodological issues

Lorna M. Stimson, L. Stimson, A. Bunker, 2008, SAR and QSAR in environmental research.

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2011, Clinical and experimental immunology.

Effects of Cysteamine Pretreatment and Hypothalamic Periventricular Nucleus Lesion on the Cold‐Stimulated Thyrotropin Responses to Intracerebroventricular 5‐Hydroxytryptamine in Male Rats

P. Tuomainen, P. Rauhala, P. Männistö, 1990, Journal of neuroendocrinology.

Inhibitors of catechol‐O‐methyltransferase sensitize mice to pain

E. Kalso, A. Pertovaara, V. Kontinen, 2010, British journal of pharmacology.

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner

J. Tenorio-Laranga, J. Garcia-horsman, T. Myöhänen, 2011, British journal of pharmacology.

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

V. Baekelandt, A. Lambeir, R. Van Elzen, 2012, British journal of pharmacology.

Comparison of two new inhibitors of catechol O‐methylation on striatal dopamine metabolism: a microdialysis study in rats

S. Kaakkola, P. Tuomainen, M. Törnwall, 1994, British journal of pharmacology.

Importance of membrane‐bound catechol‐O‐methyltransferase in L‐DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice

M. Karayiorgou, A. Tammimäki, J. Garcia-horsman, 2009, British journal of pharmacology.

Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats.

A. Haapalinna, R. Liljequist, P. Männistö, 1997, Behavioural brain research.

Degradation of coeliac disease‐inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells

K. Kaukinen, T. Mauriala, S. Auriola, 2010, Clinical and experimental immunology.

Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias

J. Palo, S. Kaakkola, P. Tuomainen, 1993, Acta neurologica Scandinavica.